Get the Stockscreener App
0.4398
4.61%
0.0194
Cosmos Health Inc stock is traded at $0.4398, with a volume of 400.18K.
It is up +4.61% in the last 24 hours and down -1.72% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.4204
Open:
$0.44
24h Volume:
400.18K
Relative Volume:
0.96
Market Cap:
$14.30M
Revenue:
$56.04M
Net Income/Loss:
$-20.39M
P/E Ratio:
-0.1802
EPS:
-2.44
Net Cash Flow:
$-6.84M
1W Performance:
+4.71%
1M Performance:
-1.72%
6M Performance:
-33.33%
1Y Performance:
-32.34%
1-Day Range:
$0.4216
$0.4736
1-Week Range:
$0.41
$0.4736
52-Week Range:
$0.2801
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.4398 | 14.30M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
720.82 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
294.12 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
164.21 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
72.68 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.48 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Cosmos Health Inc Stock (COSM) Latest News
Isaac GR00T N1: World’s first foundation model for humanoid robotics unveiled by NVIDIA - Interesting Engineering
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven - mx.advfn.com
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million - Revista ADVFN
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - The Globe and Mail
Cosmos Health CEO Grigorios Siokas acquires $15,216 in stock - Investing.com Australia
Cosmos Health CEO Grigorios Siokas acquires $15,216 in stock By Investing.com - Investing.com Canada
Cosmos health CEO acquires shares worth $82,000 By Investing.com - Investing.com South Africa
Cosmos health CEO acquires shares worth $82,000 - Investing.com Australia
Cosmos Health CEO Grigorios Siokas acquires $65,960 in stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Grigorios Siokas acquires $65,960 in stock - Investing.com
Cosmos Health CEO Grigorios Siokas acquires shares in debt exchange By Investing.com - Investing.com Nigeria
Cosmos Health CEO Grigorios Siokas acquires shares in debt exchange - Investing.com
Cosmos Health Reports Strong Q1 2025 Financial Performance and Improved Profitability Metrics - Nasdaq
COSM Reports Q1 Revenue Decline but Shows Operational Resilience - GuruFocus
Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Ac - GuruFocus
Cosmos Health Reports Q1 2025 Results: Adjusted - GlobeNewswire
Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven | COSM St - GuruFocus
Cosmos Health Inc. SEC 10-Q Report - TradingView
1 Simple Quote That Shows Why Arm Holdings Is a Buy - The Globe and Mail
Walmart (WMT) Is About to Report Q1 Earnings Tomorrow. Here Is What to Expect - The Globe and Mail
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 - GuruFocus
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units - The Manila Times
Cosmos Health Secures Follow-Up Order from Pharmalink for - GlobeNewswire
Cosmos Health Receives Additional Sky Premium Life Order From Pharmalink - marketscreener.com
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units | COSM Stock News - GuruFocus
Cosmos Health Inc. Secures Additional Order for 80,000 Units of Sky Premium Life Products in UAE - Nasdaq
Why AMD Stock Skyrocketed Wednesday Morning Before Losing Ground - The Globe and Mail
Cosmos Health (COSM) Gets Extension to Meet Nasdaq Bid Price Rul - GuruFocus
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq | COSM Stock News - GuruFocus
Cosmos Health (COSM) Gets Extension to Meet Nasdaq Bid Price Rule | COSM Stock News - GuruFocus
Cosmos Health Receives Additional 180-Day Compliance Period From Nasdaq - marketscreener.com
Cosmos Health Receives Additional Time to Comply With Nasdaq Listing Requirement - marketscreener.com
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq - The Manila Times
Cosmos Health Inc. Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Nasdaq
Cosmos Health granted Nasdaq compliance extension - Investing.com
Cosmos Health Escapes Immediate Delisting Risk: Nasdaq Grants Critical 180-Day Extension - Stock Titan
Geode Capital Management LLC Increases Stock Position in Cosmos Health Inc. (NASDAQ:COSM) - Defense World
Where Will Alphabet Be in 5 Years? - The Globe and Mail
Do Google's Antitrust Woes Make Alphabet Stock a Buy, Sell, or Hold? - The Globe and Mail
Stocks of Cosmos Health Inc (COSM) are poised to climb above their peers - Sete News
Financial Metrics Unveiled: Cosmos Health Inc (COSM)’s Key Ratios in the Spotlight - DWinneX
Behind Cosmos Health Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
Cosmos Health Inc [COSM] Shares Fall Approximately -34.71% Over the Year - knoxdaily.com
Evaluating COSM’s financial ratios for a profitable investment - uspostnews.com
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued a - GuruFocus
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 - The Manila Times
Cosmos Health CEO boosts stake with $526,000 share purchase - Investing.com
Cosmos Health CEO boosts stake with $526,000 share purchase By Investing.com - Investing.com UK
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares - GlobeNewswire
Massive Insider Buying: Cosmos Health CEO Acquires 1.4M Shares in Latest $526K Investment Spree - Stock Titan
Should You Buy PayPal Stock on the Dip in May 2025? - The Globe and Mail
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
May 22 '25 |
Buy |
0.44 |
141,825 |
62,800 |
6,124,880 |
| Siokas Grigorios | Chief Executive Officer |
May 21 '25 |
Buy |
0.47 |
174,172 |
82,000 |
5,983,055 |
| Siokas Grigorios | Chief Executive Officer |
May 20 '25 |
Buy |
0.45 |
147,563 |
65,961 |
5,808,883 |
| Siokas Grigorios | Chief Executive Officer |
May 19 '25 |
Buy |
0.43 |
79,254 |
34,000 |
5,661,320 |
| Siokas Grigorios | Chief Executive Officer |
Apr 24 '25 |
Buy |
0.40 |
254,618 |
102,000 |
5,582,066 |
| Siokas Grigorios | Chief Executive Officer |
Apr 24 '25 |
Buy |
0.40 |
177,234 |
71,000 |
5,327,448 |
| Siokas Grigorios | Chief Executive Officer |
Apr 23 '25 |
Buy |
0.40 |
205,000 |
82,000 |
5,150,214 |
| Siokas Grigorios | Chief Executive Officer |
Apr 22 '25 |
Buy |
0.36 |
175,000 |
63,000 |
4,945,214 |
| Siokas Grigorios | Chief Executive Officer |
Apr 21 '25 |
Buy |
0.32 |
654,912 |
208,000 |
4,770,214 |
| Siokas Grigorios | Chief Executive Officer |
Mar 04 '25 |
Buy |
0.53 |
85,714 |
45,000 |
4,115,302 |
1.16%
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):